Funder: National Institutes of Health
Due Dates: February 19, 2026 (estimated, forecasted)
Funding Amounts: Estimated total program funding: $3,000,000 | Award floor: $100,000 | Up to 5 years (2 years R61, 3 years R33)
Summary: Supports milestone-driven, phased clinical trials to improve health and quality-of-life for individuals with Down syndrome by addressing critical and co-occurring health conditions.
Key Information: Forecasted opportunity; all dates and details subject to change.